Kenya Murata - Concepedia

Author

Kenya Murata

Also Known As

Ayumi Murakami, K Murata, K. Murata, K.-y. Murata, K.Y. Murata, Ken-Ya Murata, Ken-ya Murata, Kenya MURATA, Kenya Murata, Ken‐ya Murata

Publications

Citations

H-Index

Concepts

All Affiliations

Wakayama Medical University Nara Medical University Fiona Stanley Hospital National Institute of Neurological Disorders and Stroke National Center of Neurology and Psychiatry

About

Kenya Murata is an author at Wakayama Medical University specializing in medicine, autoimmune disease, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	12	613
2	Arts	1	1	42
3	Public Health	1	1	11
4	Allergy	1	1	83
5	Anatomy	1	1	19

Kenya Murata

Publications

879

Citations

H-Index

Page 1

	Year	Citations
Safety and efficacy of intravenous bimagrumab in inclusion body myositis (RESILIENT): a randomised, double-blind, placebo-controlled phase 2b trial Michael G. Hanna, Umesh A. Badrising, Olivier Benvéniste, The Lancet Neurology Autoimmune DiseaseImmunologyPlacebo-controlled Phase 2BImmunotherapyMedicine	2019	128
Expression of the Costimulatory Molecule BB-1, the Ligands CTLA-4 and CD28, and their mRNA in Inflammatory Myopathies Kenya Murata, Marinos C. Dalakas American Journal Of Pathology InflammationAutoimmune DiseaseLigands Ctla-4Inflammatory MyopathiesImmunology	1999	112
Statins and Myotoxic Effects Associated With Anti-3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Autoantibodies Yurika Watanabe, Shigeaki Suzuki, Hiroaki Nishimura, Medicine RheumatologyAutoimmune DiseaseMedicineImmunologyPathology	2015	87
Clinical Features of Autoimmune Autonomic Ganglionopathy and the Detection of Subunit-Specific Autoantibodies to the Ganglionic Acetylcholine Receptor in Japanese Patients Shunya Nakane, Osamu Higuchi, Michiaki Koga, PLoS ONE ImmunodeficienciesImmunologyClinical FeaturesLips TestingAutonomic Symptoms	2015	83
Expression of the co-stimulatory molecule BB-1, the ligands CTLA-4 and CD28 and their mRNAs in chronic inflammatory demyelinating polyneuropathy Kenya Murata Brain	2000	71
Calpain inhibitor-1 protects the rat heart from ischemia-reperfusion injury: analysis by mechanical work and energetics Yoshiro Yoshikawa, Hiroji Hagihara, Yoshimi Ohga, American Journal of Physiology-Heart and Circulatory Physiology Lv PvaHeart FailureCardiovascular PharmacologyCardiovascular FunctionCellular Physiology	2004	50
A dysphagia study in patients with sporadic inclusion body myositis (s-IBM) Kenya Murata, Ken Kouda, Fumihiro Tajima, Neurological Sciences Dysphagia StudyCommon Diseases	2011	45
Balloon Dilation in Sporadic Inclusion Body Myositis Patients with Dysphagia Kenya Murata, Ken Kouda, Fumihiro Tajima, Clinical Medicine Insights Case Reports EsophagusComputational DeglutitionCatheter DilationPediatric SwallowingMedicine	2013	42
Efficacy and Safety of Bimagrumab in Sporadic Inclusion Body Myositis Anthony A. Amato, Michael G. Hanna, Pedro Machado, Neurology	2021	36
Na<sup>+</sup>/Ca<sup>2+</sup> exchange inhibition protects the rat heart from ischemia-reperfusion injury by blocking energy-wasting processes Hiroji Hagihara, Yoshiro Yoshikawa, Yoshimi Ohga, American Journal of Physiology-Heart and Circulatory Physiology Cardiac MuscleHeart FailureEnergy-wasting ProcessesHigh CaContractile Failure	2004	33

Page 1